Literature DB >> 28944703

Hospital costs for patients with lower extremity cellulitis: a retrospective population-based study.

Douglas Challener1, Jasmine Marcelin2, Sue Visscher3, Larry Baddour4.   

Abstract

OBJECTIVES: Hospital admissions for non-purulent lower extremity cellulitis (NLEC) are common and can be prolonged and costly. Newer treatment options and preventive strategies are expected to result in cost savings before implementation, but few studies have quantified the cost of conventional treatment.
METHODS: Using the Rochester Epidemiology Project, the incidence of NLEC in Olmsted County, MN in 2013 was 176.6 per 100,000 persons. The subset of patients who required hospitalization for NLEC in 2013 was determined. Hospital admissions were analyzed retrospectively using standardized cost analysis within several relevant categories.
RESULTS: Thirty-four patients had an average hospital length of stay of 4.7 days. The median total inpatient cost was $7,341. The median cost per day was $2,087, with 49% due to room and board. Antibiotics administered for treatment of NLEC contributed a median cost of $75 per day of hospitalization, and laboratory and imaging test costs were $73 and $44, respectively, per day of hospitalization.
CONCLUSION: Hospitalizations for NLEC can be costly and prolonged with room and board accounting for much of the cost. Therefore, newer management strategies should seek to reduce hospital length of stay and/or avoid inpatient admission to reduce cost.

Entities:  

Keywords:  Lower extremity cellulitis; Rochester epidemiology project; cost; hospitalization; inpatient; population-based

Mesh:

Substances:

Year:  2017        PMID: 28944703      PMCID: PMC5935496          DOI: 10.1080/21548331.2017.1384690

Source DB:  PubMed          Journal:  Hosp Pract (1995)        ISSN: 2154-8331


  24 in total

1.  Clinical characteristics associated with days to discharge among patients admitted with a primary diagnosis of lower limb cellulitis.

Authors:  Amit Garg; Jonathan Lavian; Gloria Lin; Cristina Sison; Michael Oppenheim; Bonnie Koo
Journal:  J Am Acad Dermatol       Date:  2017-01-12       Impact factor: 11.527

Review 2.  Interventions for the prevention of recurrent erysipelas and cellulitis.

Authors:  Adam Dalal; Marina Eskin-Schwartz; Daniel Mimouni; Sujoy Ray; Walford Days; Emmilia Hodak; Leonard Leibovici; Mical Paul
Journal:  Cochrane Database Syst Rev       Date:  2017-06-20

3.  The attributable clinical and economic burden of skin and skin structure infections in hospitalized patients: a matched cohort study.

Authors:  Hind T Hatoum; Kasem S Akhras; Swu-Jane Lin
Journal:  Diagn Microbiol Infect Dis       Date:  2009-07       Impact factor: 2.803

4.  The course, costs and complications of oral versus intravenous penicillin therapy of erysipelas.

Authors:  C Jorup-Rönström; S Britton; A Gavlevik; K Gunnarsson; A C Redman
Journal:  Infection       Date:  1984 Nov-Dec       Impact factor: 3.553

5.  Infectious diseases specialist management improves outcomes for outpatients diagnosed with cellulitis in the emergency department: a double cohort study.

Authors:  Shilpa R Jain; Seyed M Hosseini-Moghaddam; Philip Dwek; Kaveri Gupta; Sameer Elsayed; Guy W Thompson; Robert Dagnone; Kelly Hutt; Michael Silverman
Journal:  Diagn Microbiol Infect Dis       Date:  2017-01-03       Impact factor: 2.803

6.  Use of a medical records linkage system to enumerate a dynamic population over time: the Rochester epidemiology project.

Authors:  Jennifer L St Sauver; Brandon R Grossardt; Barbara P Yawn; L Joseph Melton; Walter A Rocca
Journal:  Am J Epidemiol       Date:  2011-03-23       Impact factor: 4.897

7.  Penicillin to prevent recurrent leg cellulitis.

Authors:  Kim S Thomas; Angela M Crook; Andrew J Nunn; Katharine A Foster; James M Mason; Joanne R Chalmers; Ibrahim S Nasr; Richard J Brindle; John English; Sarah K Meredith; Nicholas J Reynolds; David de Berker; Peter S Mortimer; Hywel C Williams
Journal:  N Engl J Med       Date:  2013-05-02       Impact factor: 91.245

8.  Incidence of lower-extremity cellulitis: a population-based study in Olmsted county, Minnesota.

Authors:  David R McNamara; Imad M Tleyjeh; Elie F Berbari; Brian D Lahr; Jeffrey W Martinez; Sultan A Mirzoyev; Larry M Baddour
Journal:  Mayo Clin Proc       Date:  2007-07       Impact factor: 7.616

9.  Costs and Consequences Associated With Misdiagnosed Lower Extremity Cellulitis.

Authors:  Qing Yu Weng; Adam B Raff; Jeffrey M Cohen; Nicole Gunasekera; Jean-Phillip Okhovat; Priyanka Vedak; Cara Joyce; Daniela Kroshinsky; Arash Mostaghimi
Journal:  JAMA Dermatol       Date:  2017-02-01       Impact factor: 10.282

10.  Developing a standardized healthcare cost data warehouse.

Authors:  Sue L Visscher; James M Naessens; Barbara P Yawn; Megan S Reinalda; Stephanie S Anderson; Bijan J Borah
Journal:  BMC Health Serv Res       Date:  2017-06-12       Impact factor: 2.655

View more
  2 in total

Review 1.  Recurrent Cellulitis: Who is at Risk and How Effective is Antibiotic Prophylaxis?

Authors:  Bin S Ong; Ravindra Dotel; Vincent Jiu Jong Ngian
Journal:  Int J Gen Med       Date:  2022-08-10

2.  Diagnosis and treatment of the invasive extension of bacteria (cellulitis) from chronic wounds utilising point-of-care fluorescence imaging.

Authors:  Charles A Andersen; Katherine McLeod; Rowena Steffan
Journal:  Int Wound J       Date:  2021-10-05       Impact factor: 3.099

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.